This document highlights IQVIA’s LAAD Analytics, which unifies patient, payer, and cost data into one longitudinal dataset. It simplifies complex brand performance analysis impacted by rebates, pricing legislation, and payer requirements. The BI tool provides prebuilt dashboards and ad-hoc queries covering patient adherence, payer approval/rejection, copay trends, and cost analytics. With scalable, technology-agnostic architecture, it delivers rapid, consistent insights for ROI assessment. LAAD enables life sciences companies to understand gross-to-net outcomes, improve market access strategies, and streamline analytics through IQVIA’s Connected Intelligence framework.

Join for free to read